Pharmaceutical Deal Trends (2010–2015) Research Report 1 | Page 2

- Which regions and therapy areas have been involved in M&A deals since 2013?
- Who are the most important players in M&A deals?
- What was the rationale behind key M&A deals?
Complete analysis of recent strategic alliances - What are the different strategic alliance deal types?
- Which key regions and therapy areas have been involved in strategic alliances since 2013?
- Which important molecule types and routes of administration have recently been involved in
strategic alliances?
- Who are the key players in strategic alliance deals?
- What was the rationale behind key strategic alliance deals?
Key Reasons to Purchase
This report will allow you to - Gain an insight into pharmaceutical deal activity via in-depth analysis of the current pharmaceutical
industry, along with a focus on the most lucrative regions and therapy areas for both M&A and
strategic deals
- Examine detailed analysis of key players, covering companies involved in M&A and strategic
alliance deals, important deal activity for all deal types, and deals involving companies with the most
numerous and highest-value deals.
- Understand how the current deals market is changing, using analysis of deals by molecule type,
route of administration, and stage of development.
- Determine the most appropriate deal activity for overcoming challenges and enhancing
performance, including detailed analysis of the rationale behind key recent deals.
Ask for Discount at – http://www.marketreportsworld.com/enquiry/request-discount/10074434
Executive summary
Introduction
Overview
Traditional Model vs. Evolving Model
Factors Promoting Deal Activity
One-Stop Solution to Current Pharmaceutical Challenges
Deal Types
Overview of Pharmaceutical Deals from 2010 to 2015
Number of Pharmaceutical Deals and Value by Year
Pharmaceutical Deals by Region
Pharmaceutical Deals by Therapy Area
Overall Deal Analysis for 2014 and 2015
Announced and Completed Deals
Number of Deals and Deal Value by Deal Type
Number of Deals and Deal Value by Quarter
Regions of Deal Occurrence
Therapy Areas Promoting Deal Activity
Key Players in Deal Activity by Number of Deals and Deal Value
Mergers and Acquisitions Deal Activity for 2014 and 2015
Mergers and Acquisitions by Type of Deal and Deal Value
Mergers and Acquisitions by Region
Mergers and Acquisitions by Therapy area
Key Players in Mergers and Acquisitions
Description of Key Deals by Value